[Remote] Senior Director, US Payer Account Management at Cytokinetics

Remote

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

Bachelor's degree with 12+ years' field-based pharmaceutical/biotech Sales and/or Marketing experience
5+ years of direct managed care experience
3+ years' experience leading a team of market access Account Directors
Strong consultative and networking capabilities

Responsibilities

Manage a team of Payer Account Directors (PADs) across multiple payers to achieve business objectives
Provide strategic guidance to the Payer Accounts Team for market readiness
Lead the team to ensure appropriate coverage/access of therapies across assigned customers
Develop the PAD team to identify barriers to access and develop solutions
Lead the team to anticipate and evaluate reimbursement scenarios
Serve as internal/external SME on US coverage, coding, payments, and financial dynamics
Provide mentorship and guidance to Account Directors in negotiations and contracting
Guide the team to support relationships with senior executives
Ensure key metrics are in place to measure success and communicate with senior leadership
Create clear messages for sales on payer trends, reimbursement changes, and billing requirements
Represent the Market Access Team at payer organization meetings
Partner with the Patient Support Services Team to ensure accurate coverage determinations

Skills

Cytokinetics

Develops drugs for muscle function disorders

About Cytokinetics

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.

South San Francisco, CaliforniaHeadquarters

1998Year Founded

$58.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Risks

Increased competition could impact market share and profitability.

Potential delays in clinical trials could hinder drug commercialization.

Dependence on strategic partnerships may expose Cytokinetics to risks if challenges arise.

Differentiation

Cytokinetics focuses on muscle activators and inhibitors for cardiovascular and neuromuscular diseases.

The company has a robust pipeline including omecamtiv mecarbil and aficamten.

Cytokinetics engages in strategic partnerships, like with Sanofi, to expand market reach.

Upsides

Recent investments indicate strong interest in muscle activators and inhibitors.

Strategic partnerships, like with Sanofi, expand market reach and potential revenue.

Significant funding from Royalty Pharma supports commercial launch and R&D advancements.

Land your dream remote job 3x faster with AI

Try Jobo Free